Tianjin Pharmaceutical Hits Day High with Strong 3.01% Intraday Surge

Tianjin Pharmaceutical Da Ren Tang Group Corp. has experienced a notable increase of 3.01% on March 17, 2026, reaching an intraday high of CNY 44.48. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 0.85% on the same day. Over the past week, Tianjin Pharmaceutical has shown a robust performance, gaining 3.5%, while the China Shanghai Composite fell by 1.78%. The company's one-year performance is particularly impressive, with a return of 37.82%, significantly outpacing the market's 18.21% return. Despite some challenges in long-term growth metrics, such as a decline in net sales over the past five years, the company maintains a strong return on equity at 39.69% and a favorable price-to-book ratio of 2.72. Additionally, the stock offers a high dividend yield of 8.68%, appealing to income-focused investors. With a market capitalization of CNY 24,493 million, Tianjin Pharmaceutical continues to be a significant player in the pharmaceuticals and biotechnology sector.